Matilda Azis

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Evaluating large language models for assessment of psychosis risk.

Evaluating large language models for assessment of psychosis risk.

Journal: NPJ digital medicine

Published: April 09, 2026

Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis.

Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis.

Journal: Frontiers in psychiatry

Published: March 05, 2026

Dopamine and Mood in Psychotic Disorders: An 18F-DOPA PET Study.

Dopamine and Mood in Psychotic Disorders: An 18F-DOPA PET Study.

Journal: JAMA psychiatry

Published: August 13, 2025

The ENTER study (E-DetectioN Tool for Emerging Mental DisoRders): general population recruitment and data integrity in online screening for psychosis risk.

The ENTER study (E-DetectioN Tool for Emerging Mental DisoRders): general population recruitment and data integrity in online screening for psychosis risk.

Journal: Frontiers in psychiatry

Published: July 14, 2025

The Mini-CAARMS: Development and Validation of a Short Version of the Comprehensive Assessment of AT Risk Mental States to Facilitate Preventive Psychiatry.

The Mini-CAARMS: Development and Validation of a Short Version of the Comprehensive Assessment of AT Risk Mental States to Facilitate Preventive Psychiatry.

Journal: Schizophrenia bulletin

Published: April 18, 2025

The semi-structured interview for bipolar at-risk states (SIBARS): psychometric properties and validation.

The semi-structured interview for bipolar at-risk states (SIBARS): psychometric properties and validation.

Journal: Journal of affective disorders

Published: November 11, 2024

Transcriptional and Neurochemical Signatures of Cerebral Blood Flow Alterations in Individuals With Schizophrenia or at Clinical High Risk for Psychosis.

Transcriptional and Neurochemical Signatures of Cerebral Blood Flow Alterations in Individuals With Schizophrenia or at Clinical High Risk for Psychosis.

Journal: Biological psychiatry

Published: July 19, 2024

Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment.

Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment.

Journal: Molecular psychiatry

Published: October 06, 2022

A brief CBT intervention for depersonalisation-derealisation disorder in psychosis: Results from a feasibility randomised controlled trial.

A brief CBT intervention for depersonalisation-derealisation disorder in psychosis: Results from a feasibility randomised controlled trial.

Journal: Journal of behavior therapy and experimental psychiatry

Published: August 14, 2022

The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis.

The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis.

Journal: Schizophrenia bulletin open

Published: July 29, 2022

Correction: Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function.

Correction: Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function.

Journal: Translational psychiatry

Published: December 01, 2021

Construct validity for computational linguistic metrics in individuals at clinical risk for psychosis: Associations with clinical ratings.

Construct validity for computational linguistic metrics in individuals at clinical risk for psychosis: Associations with clinical ratings.

Journal: Schizophrenia research

Published: August 21, 2021

Showing 1-12 of 34

Last Updated: 09/26/2026